RNAZ White background cropped.jpg
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15, 2024 07:00 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
RNAZ White background cropped.jpg
TransCode Therapeutics, Inc. Announces Closing of Public Offering
July 24, 2024 16:05 ET | TransCode Therapeutics, Inc.
Boston, MA — July 24, 2024 — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to
download.png
Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles
July 19, 2024 09:01 ET | Altamira Therapeutics Ltd
Hamilton, Bermuda, July 19, 2024 (GLOBE NEWSWIRE) -- Study shows significant reduction in aorta dilation, delayed rupture and lower mortality in established animal model of abdominal aortic...
22157.jpg
Gene Therapy R&D Market Report 2024-2034 - Gene Therapy Resurgence Fuelled by Groundbreaking Advancements, Soaring Investments and a Promising Pipeline Reshaping Medicine's Future
July 01, 2024 10:10 ET | Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy R&D Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. World revenue for Gene Therapy R&D Market is...
RNAZ White background cropped.jpg
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
June 10, 2024 07:00 ET | TransCode Therapeutics, Inc.
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
Global Epigenetics Market
Epigenetics Market Size, Share & Trends Analysis Report 2024-2030
May 21, 2024 09:12 ET | Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments), By Technology (DNA Methylation), By Application...
Global MiRNA Sequencing and Assay Market
miRNA Sequencing and Assay Market Review 2019-2023 and Forecast 2024-2029: miRNA Technologies Spearhead Custom-Tailored Therapies for Individualized Treatment
May 02, 2024 09:12 ET | Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
fulllogo_transparent_nobuffer Aanastra.png
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
May 02, 2024 06:30 ET | Aanastra Inc
Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT
download.png
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
May 01, 2024 08:47 ET | Altamira Therapeutics Ltd
Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery  Treatment of rheumatoid arthritis as one of the key therapeutic indications ...
European DNA/RNA Sample Extraction and Isolation Market
Europe DNA/RNA Sample Extraction and Isolation Research Report 2024: A $1.23 Billion Market by 2033, Driven by Rising Demand for Genomic Analysis in Research, Diagnostics, and Forensic Applications
April 30, 2024 10:49 ET | Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Europe DNA/RNA Sample Extraction and Isolation Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. ...